- Epidemiology
- Performance of the Achutha Menon Centre Diabetes Risk Score in Identifying Prevalent Diabetes in Tamil Nadu, India
-
Anu Mary Oommen, Vinod Joseph Abraham, Thirunavukkarasu Sathish, V. Jacob Jose, Kuryan George
-
Diabetes Metab J. 2017;41(5):386-392. Published online August 25, 2017
-
DOI: https://doi.org/10.4093/dmj.2017.41.5.386
-
-
3,673
View
-
36
Download
-
3
Web of Science
-
4
Crossref
-
Abstract
PDFPubReader
- Background
The Achutha Menon Centre Diabetes Risk Score (AMCDRS), which was developed in rural Kerala State, South India, had not previously been externally validated. We examined the performance of the AMCDRS in urban and rural areas in the district of Vellore in the South Indian state of Tamil Nadu, and compared it with other diabetes risk scores developed from India. MethodsWe used the data from 4,896 participants (30 to 64 years) of a cross-sectional study conducted in Vellore (2010 to 2012), to calculate the AMCDRS scores using age, family history, and waist circumference. Sensitivity, specificity, positive predictive value (PPV), and negative predictive values (NPV), and the area under the receiver operating characteristic curve (AROC) were calculated for undiagnosed and total diabetes. ResultsOf the 4,896 individuals surveyed, 274 (5.6%) had undiagnosed diabetes and 759 (15.5%) had total diabetes. The AMCDRS, with an optimum cut-point of ≥4, identified 45.0% for further testing with 59.5% sensitivity, 60.5% specificity, 9.1% PPV, 95.8% NPV, and an AROC of 0.639 (95% confidence interval [CI], 0.608 to 0.670) for undiagnosed diabetes. The corresponding figures for total diabetes were 75.1%, 60.5%, 25.9%, 93.0%, and 0.731 (95% CI, 0.713 to 0.750), respectively. The AROC for the AMCDRS was not significantly different from that of the Indian Diabetes Risk Score, the Ramachandran or the Chaturvedi risk scores for total diabetes, but was significantly lower than the AROC of the Chaturvedi score for undiagnosed diabetes. ConclusionThe AMCDRS is a simple diabetes risk score that can be used to screen for undiagnosed and total diabetes in low-resource primary care settings in India. However, it probably requires recalibration to improve its performance for undiagnosed diabetes.
-
Citations
Citations to this article as recorded by
- Evaluation of Madras Diabetes Research Foundation-Indian Diabetes Risk Score in detecting undiagnosed diabetes in the Indian population: Results from the Indian Council of Medical Research-INdia DIABetes population-based study (INDIAB-15)
Mohan Deepa, Nirmal Elangovan, Ulagamathesan Venkatesan, Hiranya Kumar Das, Lobsang Jampa, Prabha Adhikari, Prashant P. Joshi, Richard O. Budnah, Vizolie Suokhrie, Mary John, Karma Jigme Tobgay, Radhakrishnan Subashini, Rajendra Pradeepa, Ranjit Mohan Anj Indian Journal of Medical Research.2023; 157(4): 239. CrossRef - Evaluating the Performance of the Indian Diabetes Risk Score in Different Ethnic Groups
Manjula D. Nugawela, Sobha Sivaprasad, Viswanathan Mohan, Ramachandran Rajalakshmi, Gopalakrishnan Netuveli Diabetes Technology & Therapeutics.2020; 22(4): 285. CrossRef - Targeted screening for prediabetes and undiagnosed diabetes in a community setting in India
Thirunavukkarasu Sathish, Jonathan E. Shaw, Robyn J. Tapp, Rory Wolfe, Kavumpurathu R. Thankappan, Sajitha Balachandran, Brian Oldenburg Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2019; 13(3): 1785. CrossRef - OBSERVATIONAL STUDY EVALUATING ASSOCIATION OF TYPE 2 DIABETES MELLITUS AND THYROID DYSFUNCTION
Elizabeth Jacob, Vivek Koshy Varghese, Tittu Oommen Journal of Evidence Based Medicine and Healthcare.2018; 5(31): 2285. CrossRef
|